Jin W - Search Results

1

Liver cirrhosis: molecular mechanisms and therapeutic interventions.

Dong Z, Wang Y, Jin W. Dong Z, et al. Among authors: jin w. MedComm (2020). 2024 Sep 17;5(10):e721. doi: 10.1002/mco2.721. eCollection 2024 Oct. MedComm (2020). 2024. PMID: 39290252 Free PMC article. Review.

2

Midnolin-proteasome pathway for protein degradation.

Jin WL. Jin WL. MedComm (2020). 2023 Dec 10;4(6):e450. doi: 10.1002/mco2.450. eCollection 2023 Dec. MedComm (2020). 2023. PMID: 38084259 Free PMC article.

3

Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential.

Pi YN, Qi WC, Xia BR, Lou G, Jin WL. Pi YN, et al. Front Immunol. 2021 Jul 6;12:697083. doi: 10.3389/fimmu.2021.697083. eCollection 2021. Front Immunol. 2021. PMID: 34295338 Free PMC article. Review.

4

Mesenchymal stem cells-based therapy in liver diseases.

Han HT, Jin WL, Li X. Han HT, et al. Mol Biomed. 2022 Jul 27;3(1):23. doi: 10.1186/s43556-022-00088-x. Mol Biomed. 2022. PMID: 35895169 Free PMC article. Review.

5

Intercellular communication in the tumour microecosystem: Mediators and therapeutic approaches for hepatocellular carcinoma.

Wang WT, Jin WL, Li X. Wang WT, et al. Biochim Biophys Acta Mol Basis Dis. 2022 Dec 1;1868(12):166528. doi: 10.1016/j.bbadis.2022.166528. Epub 2022 Aug 23. Biochim Biophys Acta Mol Basis Dis. 2022. PMID: 36007784 Free article. Review.

6

Diapause-like Drug-Tolerant Persister State: The Key to Nirvana Rebirth.

Chen HL, Jin WL. Chen HL, et al. Medicina (Kaunas). 2024 Jan 28;60(2):228. doi: 10.3390/medicina60020228. Medicina (Kaunas). 2024. PMID: 38399515 Free PMC article. Review.

7

Drug repurposing for cancer therapy.

Xia Y, Sun M, Huang H, Jin WL. Xia Y, et al. Signal Transduct Target Ther. 2024 Apr 19;9(1):92. doi: 10.1038/s41392-024-01808-1. Signal Transduct Target Ther. 2024. PMID: 38637540 Free PMC article. Review.

8

Neoantigen Specific T Cells Derived From T Cell-Derived Induced Pluripotent Stem Cells for the Treatment of Hepatocellular Carcinoma: Potential and Challenges.

Lu F, Ma XJ, Jin WL, Luo Y, Li X. Lu F, et al. Front Immunol. 2021 May 13;12:690565. doi: 10.3389/fimmu.2021.690565. eCollection 2021. Front Immunol. 2021. PMID: 34054880 Free PMC article. Review.

9

Deubiquitinating Enzymes Orchestrate the Cancer Stem Cell-Immunosuppressive Niche Dialogue: New Perspectives and Therapeutic Potential.

Guo JN, Xia BR, Deng SH, Yang C, Pi YN, Cui BB, Jin WL. Guo JN, et al. Front Cell Dev Biol. 2021 Jun 9;9:680100. doi: 10.3389/fcell.2021.680100. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34179009 Free PMC article. Review.

10

Exosomes: Powerful weapon for cancer nano-immunoengineering.

Pi YN, Xia BR, Jin MZ, Jin WL, Lou G. Pi YN, et al. Biochem Pharmacol. 2021 Apr;186:114487. doi: 10.1016/j.bcp.2021.114487. Epub 2021 Feb 27. Biochem Pharmacol. 2021. PMID: 33647264 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,666 results

Search Page

Filters